KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Shares Issued: 2010-2025

Historic Shares Issued for Emergent BioSolutions (EBS) over the last 13 years, with Sep 2025 value amounting to $200,000.

  • Emergent BioSolutions' Shares Issued fell 98.43% to $200,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 37.16%. This contributed to the annual value of $13.4 million for FY2024, which is 59.52% up from last year.
  • Per Emergent BioSolutions' latest filing, its Shares Issued stood at $200,000 for Q3 2025, which was down 71.43% from $700,000 recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Shares Issued ranged from a high of $12.7 million in Q3 2024 and a low of $100,000 during Q1 2025.
  • In the last 3 years, Emergent BioSolutions' Shares Issued had a median value of $700,000 in 2025 and averaged $3.3 million.
  • Its Shares Issued has fluctuated over the past 5 years, first spiked by 228.00% in 2023, then crashed by 98.43% in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Shares Issued stood at $3.4 million in 2021, then plummeted by 41.18% to $2.0 million in 2022, then plummeted by 90.00% to $200,000 in 2023, then crashed by 91.46% to $12.7 million in 2024, then tumbled by 98.43% to $200,000 in 2025.
  • Its Shares Issued was $200,000 in Q3 2025, compared to $700,000 in Q2 2025 and $100,000 in Q1 2025.